Despite recent advances in treatment, cardiovascular diseases continue to be leading causes of mortality in the United States. Major congenital malformations of heart valves and the great arteries also present significant challenges, since children who require valve or arterial replacement typically outgrow the replacement structures. The substitute heart valves and blood vessels currently available have significant limitations; presently, autologous tissue replacements appear to provide the best combination of safety, performance and longevity. To improve upon existing heart valve and vessel replacement options, the collaborators (Drs. Mayer, Vacanti, and Langer) have tissue-engineered single pulmonary valve leaflets from autologous vascular cells and shown that these structures function for months in a growing lamb. This dramatic result was achieved without an in-depth knowledge of the cellular and molecular properties of native valves. The investigators hypothesize that cardiac valves have unique properties that are important for structure and function. Furthermore, understanding these unique properties at a biochemical and molecular level will be required to fully optimize and exploit the tissue-engineering of vascular replacement structures. Towards this end, the investigators propose to analyze and define the biochemical and functional properties of endothelial and stromal cells of normal human and ovine pulmonary valves. Second, the investigators will analyze tissue-engineered structures produced by Drs. Mayer, Vacanti, and Langer for expression of biochemical markers present in normal valves. Third, the investigators will identify regulated genes by a suppression subtractive hybridization approach. These studies will allow the investigators to define differential expression of both known and novel genes in the endothelial and stromal cells of normal valves and in tissue-engineered vascular structures. The same experimental approach will be applied to large and small arteries. The ability to study vascular cells in vitro and then in vivo provides a unique opportunity to analyze vascular growth and remodeling at a molecular level.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL060490-03
Application #
6184502
Study Section
Special Emphasis Panel (ZHL1-CSR-F (M1))
Project Start
1998-07-10
Project End
2003-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
3
Fiscal Year
2000
Total Cost
$330,000
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Wylie-Sears, Jill; Aikawa, Elena; Levine, Robert A et al. (2011) Mitral valve endothelial cells with osteogenic differentiation potential. Arterioscler Thromb Vasc Biol 31:598-607
Jang, Gun Hyuk; Park, In-Sook; Yang, Jeong Hee et al. (2010) Differential functions of genes regulated by VEGF-NFATc1 signaling pathway in the migration of pulmonary valve endothelial cells. FEBS Lett 584:141-6
Yang, Jeong-Hee; Wylie-Sears, Jill; Bischoff, Joyce (2008) Opposing actions of Notch1 and VEGF in post-natal cardiac valve endothelial cells. Biochem Biophys Res Commun 374:512-6
Lee, You Mie; Cope, John J; Ackermann, Gabriele E et al. (2006) Vascular endothelial growth factor receptor signaling is required for cardiac valve formation in zebrafish. Dev Dyn 235:29-37
Paruchuri, Sailaja; Yang, Jeong-Hee; Aikawa, Elena et al. (2006) Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ Res 99:861-9
Armstrong, Ehrin J; Bischoff, Joyce (2004) Heart valve development: endothelial cell signaling and differentiation. Circ Res 95:459-70
Dvorin, Evan L; Jacobson, Joel; Roth, Stephen J et al. (2003) Human pulmonary valve endothelial cells express functional adhesion molecules for leukocytes. J Heart Valve Dis 12:617-24
Johnson, Ehrin N; Lee, You Mie; Sander, Tara L et al. (2003) NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J Biol Chem 278:1686-92
Dvorin, Evan L; Wylie-Sears, Jill; Kaushal, Sunjay et al. (2003) Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth facto Tissue Eng 9:487-93
Perry, Tjorvi E; Roth, Stephen J (2003) Cardiovascular tissue engineering: constructing living tissue cardiac valves and blood vessels using bone marrow, umbilical cord blood, and peripheral blood cells. J Cardiovasc Nurs 18:30-7

Showing the most recent 10 out of 12 publications